Britannin inhibits hepatocellular carcinoma development and metastasis through the GSK-3β/β-catenin signaling pathway
In conclusion, britannin could inhibit the growth, development and metastasis of HCC, and its mechanism may be related to the regulation of GSK-3β/β-catenin signaling pathway to inhibit epithelial-mesenchymal transition of HCC.
Authors
- Linxin Teng (ORCID: https://orcid.org/0000-0002-2948-3179)
- Junlin Zhu (ORCID: https://orcid.org/0009-0007-6969-9824)
- Weiping Chen (ORCID: https://orcid.org/0000-0001-8540-5338)
- C. Chen (ORCID: https://orcid.org/0009-0000-8084-4040)
- Qinwei Lu
- Lei Bi
Institutions
- Macau University of Science and Technology (MO)
- Nanjing University of Chinese Medicine (CN)
Publication Details
- Journal
- Phytomedicine
- Published
- 2024-10-02
- DOI
- https://doi.org/10.1016/j.phymed.2024.156126
- Citations
- 11
- Primary Topic
- Natural product bioactivities and synthesis
- Type
- article
- Field-Weighted Citation Impact
- 2.57